Publication | Open Access
Rapid Drug Susceptibility Testing with a Molecular Beacon Assay Is Associated with Earlier Diagnosis and Treatment of Multidrug-Resistant Tuberculosis in California
20
Citations
7
References
2010
Year
Mdr TbDrug ResistanceMultidrug-resistant TuberculosisMolecular BeaconDrug TestMb AssayPreventive TreatmentTuberculosis DiagnosticsMolecular DiagnosticsAntimicrobial ResistanceHealth SciencesTherapeutic Drug MonitoringPulmonary TuberculosisDrug Resistance AnalysisTuberculosisPharmacologyAntimicrobial SusceptibilityDrug TestingEarlier DiagnosisMedicine
To assess the clinical impact of a molecular beacon (MB) assay that detects multidrug-resistant tuberculosis (MDR TB), we retrospectively reviewed records of 127 MDR TB patients with and without MB testing between 2004 and 2007. Use of the MB assay reduced the time to detection and treatment of MDR TB.
| Year | Citations | |
|---|---|---|
Page 1
Page 1